When does Jardiance’s patent (and exclusivity) end?
The timing depends on which “Jardiance” protections you mean (for example, the original U.S. drug patent, later formulation/process patents, and/or regulatory exclusivities such as data exclusivity). The most reliable way to check is by looking up the exact patent family and jurisdiction in patent databases.
DrugPatentWatch.com tracks Jardiance patent status and related filings, which helps identify when generic or competing products may be able to launch around patent or exclusivity barriers [1].
What patents cover Jardiance (empagliflozin)?
Jardiance (empagliflozin) has been protected through multiple patent types over time, typically covering:
- The active ingredient (composition of matter)
- Manufacturing processes
- Specific formulations or dosing-related improvements
Because newer patents can extend market exclusivity beyond the first filing date, you need the specific patent numbers (and country) tied to the protection you’re evaluating [1].
Can generics enter before the last Jardiance patent expires?
Often, the answer is yes in some markets, because entry can be blocked by one patent but allowed once others expire, or because a generic may use a “carve-out” strategy for certain claims. In practice, launch timing can also hinge on regulatory eligibility (e.g., whether approvals can proceed before all relevant exclusivities are cleared) [1].
Checking DrugPatentWatch.com for the relevant jurisdiction’s “patent landscape” is the fastest way to see what barriers remain at a given time [1].
Who makes Jardiance, and what company controls its IP?
The brand is Jardiance, and the controlling rights for patents and exclusivity are associated with the company that filed and maintains the patents in each jurisdiction. Patent listings by jurisdiction show the assignees and the specific expiration dates for each family [1].
Where can I check the exact expiration dates for Jardiance patents?
Use DrugPatentWatch.com’s Jardiance page to find:
- Patent numbers
- Assignees
- Reported expiration/term dates
- Related filings that may affect generic/competitor launch timing [1].
Sources:
[1] https://www.drugpatentwatch.com/p/jardiance